Efficacy of Acupuncture and Moxibustion Treatment in Patients With Quiescent Crohn's Disease:Evaluation With fMRI
NCT ID: NCT01696838
Last Updated: 2016-09-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
61 participants
INTERVENTIONAL
2012-09-30
2014-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Acupuncture and Moxibustion Treatment in Patients With Active Crohn's Disease
NCT01697761
Effect of Acupuncture on the Microbiota-gut-brain Axis in Crohn's Disease
NCT06364722
Effect of Acupuncture on Quiescent Crohn's Disease
NCT04198831
Acupuncture Treatment for Active Crohn's Disease
NCT02559037
Effect of Acupuncture on Patients With Crohn's Disease in Remission
NCT04211129
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Through treating quiescent Crohn's disease by electroacupuncture or moxibustion therapies for 12 weeks, Compare the different brain activation by the different therapies and observe the correlation between brain activation and efficacy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EA group
Electroacupuncture group
electroacupuncture
Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.
moxibustion
patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.
MOX group
Herbs-partitioned moxibustion group
electroacupuncture
Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.
moxibustion
patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
electroacupuncture
Patients receive electroacupuncture for 30 minutes with a stimulation frequency of 2 /100 Hz and a stimulation intensity varying from 0.1 to 1.0 mA.3 times per week,the duration is 12 weeks.
moxibustion
patients receive herbs-partitioned moxibustion for 2 cones,3 times a week for 12 weeks.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* right-handed;
* clinical remission (Crohn's Disease Activity Index \[CDAI\]≤150) for at least 6 months prior to the study;
* C-reactive protein(CRP)\<10 mg/l;
* erythrocyte sedimentation rate (ESR) \<20 mm/h
* signing awritten informed consent form.
Exclusion Criteria
* current or prior history of neurological or psychiatric disease based
* on physicians' examination and questionnaires;
* current or prior history of neurosurgery, head injury, cerebrovascular
* insult, or brain trauma involving loss of consciousness;
* learning disability;
* claustrophobia;
* presence of metallic implants in the body;
* being pregnant or during lactation.
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Institute of Acupuncture, Moxibustion and Meridian
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wu Huangan, PhD
Role: STUDY_CHAIR
Shanghai Institute of Acupuncture, Moxibustion and Meridian
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Shanghai Institute of Acupuncture-Moxibustion and Merdian
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHACU-201201
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.